These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7635447)

  • 1. Pathology of tumor-stroma interaction in melanoma metastatic to the skin.
    Smolle J; Woltsche I; Hofmann-Wellenhof R; Haas J; Kerl H
    Hum Pathol; 1995 Aug; 26(8):856-61. PubMed ID: 7635447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of two morphologic parameters concerning tumor-stroma interaction in benign and malignant melanocytic skin lesions.
    Fink-Puches R; Smolle J; Hofmann-Wellenhof R; Kerl H
    Am J Dermatopathol; 1998 Oct; 20(5):468-72. PubMed ID: 9790107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and histological features of poor prognosis in cutaneous metastatic melanomas.
    Hofmann-Wellenhof R; Woltsche-Kahr I; Smolle J; Kerl H
    J Cutan Pathol; 1996 Jun; 23(3):199-204. PubMed ID: 8793653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of fat cells in subcutaneous metastatic melanoma. Correlation with outcome.
    Smolle J; Hofmann-Wellenhof R; Woltsche-Kahr I; Haas J; Kerl H
    Am J Dermatopathol; 1995 Dec; 17(6):555-9. PubMed ID: 8599468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of tumorigenic malignant melanomas to dermal elastin: an expression of tumor/stromal interaction that may be related to prognosis.
    Feinmesser M; Schachter JM; Tobar A; Sulkes J; Gutman H; Kruk N; Okon E
    Am J Dermatopathol; 2002 Apr; 24(2):108-17. PubMed ID: 11979070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal reaction in cutaneous melanoma.
    Labrousse AL; Ntayi C; Hornebeck W; Bernard P
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):269-75. PubMed ID: 15036266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of pre-existing collagen bundles in primary cutaneous melanoma.
    Smolle J; Hofmann-Wellenhof R; Pfaffentaler E; Fink-Puches R; Kerl H
    Melanoma Res; 1998 Apr; 8(2):161-5. PubMed ID: 9610870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
    Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
    Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma and stroma: an interaction of biological and prognostic importance.
    Smolle J; Hofmann-Wellenhof R; Fink-Puches R
    Semin Cutan Med Surg; 1996 Dec; 15(4):326-35. PubMed ID: 9069600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of intratumoral and peritumoral lymphocytes and lymphocyte score based on the histologic subtypes of cutaneous melanoma.
    Park CK; Kim SK
    Oncotarget; 2017 Feb; 8(9):14759-14769. PubMed ID: 28107203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma.
    Falleni M; Savi F; Tosi D; Agape E; Cerri A; Moneghini L; Bulfamante GP
    Melanoma Res; 2017 Jun; 27(3):200-210. PubMed ID: 28272106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological findings suggestive of interclonal stabilization in a case of cutaneous melanoma.
    Okcu A; Hofmann-Wellenhof R; Woltsche I; Smolle J; Kerl H
    Clin Exp Metastasis; 1996 May; 14(3):215-8. PubMed ID: 8674275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma.
    Thies A; Schachner M; Berger J; Moll I; Schulze HJ; Brunner G; Schumacher U
    J Pathol; 2004 Aug; 203(4):933-9. PubMed ID: 15258996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of B-cell density in cutaneous melanoma.
    Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
    Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.
    Monteagudo C; Martin JM; Jorda E; Llombart-Bosch A
    J Clin Pathol; 2007 Jun; 60(6):596-9. PubMed ID: 16522748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
    Špirić Z; Eri Ž; Erić M
    Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenascin-C in primary malignant melanoma of the skin.
    Ilmonen S; Jahkola T; Turunen JP; Muhonen T; Asko-Seljavaara S
    Histopathology; 2004 Oct; 45(4):405-11. PubMed ID: 15469480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M; Chosia M; Domagała W
    Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.